Matches in Wikidata for { <http://www.wikidata.org/entity/Q91368102> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- Q91368102 description "article scientifique publié en 2018" @default.
- Q91368102 description "artículu científicu espublizáu en setiembre de 2018" @default.
- Q91368102 description "im September 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91368102 description "scientific article published on 07 September 2018" @default.
- Q91368102 description "wetenschappelijk artikel" @default.
- Q91368102 description "наукова стаття, опублікована у вересні 2018" @default.
- Q91368102 name "A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition: The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human" @default.
- Q91368102 name "A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition: The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human" @default.
- Q91368102 type Item @default.
- Q91368102 label "A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition: The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human" @default.
- Q91368102 label "A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition: The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human" @default.
- Q91368102 prefLabel "A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition: The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human" @default.
- Q91368102 prefLabel "A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition: The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human" @default.
- Q91368102 P1433 Q91368102-D8FA180C-465D-4EE7-9075-B92DD919D9A0 @default.
- Q91368102 P1476 Q91368102-8A75B507-0B72-46B0-BA08-217C9F8667C3 @default.
- Q91368102 P2093 Q91368102-0DE4E561-0E2D-4412-AAA9-AF0E1B658851 @default.
- Q91368102 P2093 Q91368102-3AD90BEE-2D32-4BF4-9637-961EBE1D206D @default.
- Q91368102 P2093 Q91368102-45A9C022-DBF0-4110-ABDE-1E4CA272990A @default.
- Q91368102 P2093 Q91368102-4CE31C82-42DA-48BC-BC06-CC6D1F1597B5 @default.
- Q91368102 P2093 Q91368102-5F26E584-FCDE-4104-B557-637344433475 @default.
- Q91368102 P2093 Q91368102-66F26304-66AE-4B8B-A94B-E6B02F60975D @default.
- Q91368102 P2093 Q91368102-710496B2-2B4D-4756-8C5F-E063F74FC1B7 @default.
- Q91368102 P2093 Q91368102-7C115174-ABC1-4338-823C-1E50D0CB274D @default.
- Q91368102 P2093 Q91368102-AAD7FC59-28A7-439B-919D-DF02E576683B @default.
- Q91368102 P2093 Q91368102-AB0C825B-BDD5-4CC9-8DFF-D28DDE29C5FC @default.
- Q91368102 P2093 Q91368102-AD835AC3-9D83-402B-BBEB-59D39D0ED9F3 @default.
- Q91368102 P2093 Q91368102-B2B74904-22A2-48FB-B274-BD7388D426BA @default.
- Q91368102 P2093 Q91368102-B91E0968-3D9A-401C-8FF9-B9C190B6096A @default.
- Q91368102 P2093 Q91368102-B976759A-1AE1-4A1A-A049-205B103DC235 @default.
- Q91368102 P2093 Q91368102-DB6DE8A5-2385-4EE2-8D30-48B86F837907 @default.
- Q91368102 P304 Q91368102-9D074692-85DE-44AE-A33B-0E32CA0461F5 @default.
- Q91368102 P31 Q91368102-111C666A-0F54-45C4-A4E2-936238557043 @default.
- Q91368102 P356 Q91368102-600DAD46-68A7-4A13-8D67-F61EB45E1C1D @default.
- Q91368102 P433 Q91368102-93520B95-CA9C-496D-B151-DFADBA806865 @default.
- Q91368102 P478 Q91368102-09092A4A-B476-4958-8117-ACFF6CD511D8 @default.
- Q91368102 P50 Q91368102-0CF63DF3-18E9-4071-BB57-EAD9BFC84418 @default.
- Q91368102 P50 Q91368102-10FCB92A-C7CC-4252-B2F0-49956349A4CE @default.
- Q91368102 P50 Q91368102-588B8825-92E1-4A71-8DAE-17DC7A618D56 @default.
- Q91368102 P50 Q91368102-9CD7EE37-D6E3-4E4A-B794-9AAEB39E6FD7 @default.
- Q91368102 P577 Q91368102-A92D8ADF-743B-4132-A598-63386A6C9FB5 @default.
- Q91368102 P698 Q91368102-AE16FB96-A4D7-4FBD-BBA0-26F1F66DC611 @default.
- Q91368102 P921 Q91368102-1C83E245-8755-444C-9ABF-085E379DFE75 @default.
- Q91368102 P356 J.EURURO.2018.08.029 @default.
- Q91368102 P698 30201510 @default.
- Q91368102 P1433 Q15763991 @default.
- Q91368102 P1476 "A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition: The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human Use Does not Change Evidence-based Guideline Recommendations" @default.
- Q91368102 P2093 "Alessandro Volpe" @default.
- Q91368102 P2093 "Axel Bex" @default.
- Q91368102 P2093 "Axel S Merseburger" @default.
- Q91368102 P2093 "Bernard Escudier" @default.
- Q91368102 P2093 "Börje Ljungberg" @default.
- Q91368102 P2093 "Fabian Hofmann" @default.
- Q91368102 P2093 "Karim Bensalah" @default.
- Q91368102 P2093 "Lorenzo Marconi" @default.
- Q91368102 P2093 "Markus A Kuczyk" @default.
- Q91368102 P2093 "Michael Staehler" @default.
- Q91368102 P2093 "Rana Tahbaz" @default.
- Q91368102 P2093 "Saeed Dabestani" @default.
- Q91368102 P2093 "Thomas B Lam" @default.
- Q91368102 P2093 "Thomas Powles" @default.
- Q91368102 P2093 "Yasmin Abu-Ghanem" @default.
- Q91368102 P304 "849-851" @default.
- Q91368102 P31 Q13442814 @default.
- Q91368102 P356 "10.1016/J.EURURO.2018.08.029" @default.
- Q91368102 P433 "6" @default.
- Q91368102 P478 "74" @default.
- Q91368102 P50 Q51504981 @default.
- Q91368102 P50 Q54553347 @default.
- Q91368102 P50 Q63372740 @default.
- Q91368102 P50 Q83196399 @default.
- Q91368102 P577 "2018-09-07T00:00:00Z" @default.
- Q91368102 P698 "30201510" @default.
- Q91368102 P921 Q3242950 @default.